Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > RBC is a retail seller imo

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron Feb 12, 2021 9:49am

45 Views

Post# 32551013

RBC is a retail seller imo

Recent Trades - Last 10 of 60

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
09:48:30	V	0.475	-0.025	500	2 RBC	2 RBC	K
09:48:30	V	0.475	-0.025	1,500	2 RBC	2 RBC	K
09:48:30	V	0.48	-0.02	4,000	7 TD Sec	2 RBC	K
09:44:36	V	0.475	-0.04	180	80 National Bank	68 Leede
09:44:21	V	0.48	-0.04	100	2 RBC	68 Leede
09:44:21	V	0.48	-0.04	10	7 TD Sec	68 Leede
09:44:21	V	0.46	-0.04	500	79 CIBC	2 RBC	K
09:44:21	V	0.46	-0.04	500	9 BMO Nesbitt	2 RBC	K
09:44:21	V	0.46	-0.04	1,000	7 TD Sec	2 RBC	K
09:44:21	V	0.46	-0.04	500	7 TD Sec	2 RBC	K